How have clinical trials received a pandemic boost for product development?
The pandemic has given a strong tailwind to the clinical trials market, which is now valued at over US$67 billion, according to CB Insights. The game is to speed up product development using big data and artificial intelligence (AI), crunching time to market. Clinical trials involve a lengthy process of the regulatory approval process for drugs, devices, and digital therapies. However, the time and cost to complete them are prohibitive, and the likelihood of regulatory approval is low. This is where technology is coming into play to accelerate clinical trials and quicken drug development, besides enhancing the accuracy of the outcome of the trials.
Real-W...
How clinical trials get a pandemic push? ⭐
Date: